miRNA-223 Promotes Gastric Cancer Invasion and Metastasis by Targeting Tumor Suppressor EPB41L3

  • Xiaohua Li
    Authors' Affiliations: 1State Key Laboratory of Cancer Biology & Xijing Hospital of Digestive Diseases; and 2Department of Dermatology, the Fourth Military Medical University, Xi'an, China
  • Ying Zhang
    Authors' Affiliations: 1State Key Laboratory of Cancer Biology & Xijing Hospital of Digestive Diseases; and 2Department of Dermatology, the Fourth Military Medical University, Xi'an, China
  • Hongwei Zhang
    Authors' Affiliations: 1State Key Laboratory of Cancer Biology & Xijing Hospital of Digestive Diseases; and 2Department of Dermatology, the Fourth Military Medical University, Xi'an, China
  • Xiaonan Liu
    Authors' Affiliations: 1State Key Laboratory of Cancer Biology & Xijing Hospital of Digestive Diseases; and 2Department of Dermatology, the Fourth Military Medical University, Xi'an, China
  • Taiqian Gong
    Authors' Affiliations: 1State Key Laboratory of Cancer Biology & Xijing Hospital of Digestive Diseases; and 2Department of Dermatology, the Fourth Military Medical University, Xi'an, China
  • Mengbin Li
    Authors' Affiliations: 1State Key Laboratory of Cancer Biology & Xijing Hospital of Digestive Diseases; and 2Department of Dermatology, the Fourth Military Medical University, Xi'an, China
  • Li Sun
    Authors' Affiliations: 1State Key Laboratory of Cancer Biology & Xijing Hospital of Digestive Diseases; and 2Department of Dermatology, the Fourth Military Medical University, Xi'an, China
  • Yongquan Shi
    Authors' Affiliations: 1State Key Laboratory of Cancer Biology & Xijing Hospital of Digestive Diseases; and 2Department of Dermatology, the Fourth Military Medical University, Xi'an, China
  • Zheyi Han
    Authors' Affiliations: 1State Key Laboratory of Cancer Biology & Xijing Hospital of Digestive Diseases; and 2Department of Dermatology, the Fourth Military Medical University, Xi'an, China
  • Shuang Han
    Authors' Affiliations: 1State Key Laboratory of Cancer Biology & Xijing Hospital of Digestive Diseases; and 2Department of Dermatology, the Fourth Military Medical University, Xi'an, China
  • Yongzhang Nie
    Authors' Affiliations: 1State Key Laboratory of Cancer Biology & Xijing Hospital of Digestive Diseases; and 2Department of Dermatology, the Fourth Military Medical University, Xi'an, China
  • Xiong Chen
    Authors' Affiliations: 1State Key Laboratory of Cancer Biology & Xijing Hospital of Digestive Diseases; and 2Department of Dermatology, the Fourth Military Medical University, Xi'an, China
  • Qinchuan Zhao
    Authors' Affiliations: 1State Key Laboratory of Cancer Biology & Xijing Hospital of Digestive Diseases; and 2Department of Dermatology, the Fourth Military Medical University, Xi'an, China
  • Jie Ding
    Authors' Affiliations: 1State Key Laboratory of Cancer Biology & Xijing Hospital of Digestive Diseases; and 2Department of Dermatology, the Fourth Military Medical University, Xi'an, China
  • Kaichun Wu
    Authors' Affiliations: 1State Key Laboratory of Cancer Biology & Xijing Hospital of Digestive Diseases; and 2Department of Dermatology, the Fourth Military Medical University, Xi'an, China
  • Fan Daiming
    Authors' Affiliations: 1State Key Laboratory of Cancer Biology & Xijing Hospital of Digestive Diseases; and 2Department of Dermatology, the Fourth Military Medical University, Xi'an, China

書誌事項

公開日
2011-07-01
DOI
  • 10.1158/1541-7786.mcr-10-0529
公開者
American Association for Cancer Research (AACR)

この論文をさがす

説明

<jats:title>Abstract</jats:title> <jats:p>Traditional research modes aim to find cancer-specific single therapeutic target. Recently, emerging evidence suggested that some micro-RNAs (miRNA) can function as oncogenes or tumor suppressors. miRNAs are single-stranded, small noncoding RNA genes that can regulate hundreds of downstream target genes. In this study, we evaluated the miRNA expression patterns in gastric carcinoma and the specific role of miR-223 in gastric cancer metastasis. miRNA expression signature was first analyzed by real-time PCR on 10 paired gastric carcinomas and confirmed in another 20 paired gastric carcinoma tissues. With the 2-fold expression difference as a cutoff level, we identified 22 differential expressed mature miRNAs. Sixteen miRNAs were upregulated in gastric carcinoma, including miR-223, miR-21, miR-23b, miR-222, miR-25, miR-23a, miR-221, miR-107, miR-103, miR-99a, miR-100, miR-125b, miR-92, miR-146a, miR-214 and miR-191, and six miRNAs were downregulated in gastric carcinoma, including let-7a, miR-126, miR-210, miR-181b, miR-197, and miR-30aa-5p. After examining these miRNAs in several human gastric originated cell lines, we found that miR-223 is overexpressed only in metastatic gastric cancer cells and stimulated nonmetastatic gastric cancer cells migration and invasion. Mechanistically, miR-223, induced by the transcription factor Twist, posttranscriptionally downregulates EPB41L3 expression by directly targeting its 3′-untranslated regions. Significantly, overexpression of miR-223 in primary gastric carcinomas is associated with poor metastasis-free survival. These findings indicate a new regulatory mode, namely, specific miRNA, which is activated by its upstream transcription factor, could suppress its direct targets and lead to tumor invasion and metastasis. Mol Cancer Res; 9(7); 824–33. ©2011 AACR.</jats:p>

収録刊行物

  • Molecular Cancer Research

    Molecular Cancer Research 9 (7), 824-833, 2011-07-01

    American Association for Cancer Research (AACR)

被引用文献 (4)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ